Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Impact of the Pharmaceutical Care on the Quality of Life in Patients With Chagas Heart Disease (ChagasCare)

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2016 by Evandro Chagas Institute of Clinical Research
Sponsor:
Collaborators:
Alejandro Marcel Hasslocher Moreno, MD MSc PhD student
Andrea Costa, MD PhD
Andrea Silvestre de Sousa, MD PhD
Luiz Henrique C. Sangenis, MD MSc PhD student
Marcelo Teixeira de Holanda, MD MSc PhD student
Mayara da Costa Chambela - MSc student
Pedro Emmanuel Alvarenga Americano do Brasil, MD PhD
Roberto Magalhães Saraiva, MD PhD
Sergio Salles Xavier, MD PhD
Information provided by (Responsible Party):
Gilberto Marcelo Sperandio da Silva, Evandro Chagas Institute of Clinical Research
ClinicalTrials.gov Identifier:
NCT01566617
First received: March 23, 2012
Last updated: January 20, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2017
  Estimated Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):